Gardant Global Inc. – Trademark Portfolio
Entity Type: 03
Gardant Global Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 5 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include SELLTOUSA.COM, SELLTOGOVERNMENT.COM, and GARDANT TECHNOLOGIES CREATING READINESS FOR ALL THAT LIES AHEAD. The owner is based in Deerfield Beach, FL.
1409 SE 17th Terrace
Deerfield Beach, FL 33441
Showing of trademarks Trademarks
Trademark Classifications
Gardant Global Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Gardant Global Inc. have?
Gardant Global Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does Gardant Global Inc. file in?
Gardant Global Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are Gardant Global Inc.'s most well-known trademarks?
Gardant Global Inc.'s registered trademark portfolio includes well-known marks such as SELLTOUSA.COM, SELLTOGOVERNMENT.COM, and GARDANT TECHNOLOGIES CREATING READINESS FOR ALL THAT LIES AHEAD. These are among 5 currently registered trademarks in the portfolio.
What is Gardant Global Inc.'s trademark registration success rate?
Gardant Global Inc. has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.